Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.

Kramer K, Gerald W, LeSauteur L, Uri Saragovi H, Cheung NK.

Clin Cancer Res. 1996 Aug;2(8):1361-7.

2.

Monoclonal antibody to human Trk-A: diagnostic and therapeutic potential in neuroblastoma.

Kramer K, Gerald W, LeSauteur L, Saragovi HU, Cheung NK.

Eur J Cancer. 1997 Oct;33(12):2090-1.

PMID:
9516859
3.

Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.

Eggert A, Ikegaki N, Liu XG, Brodeur GM.

Klin Padiatr. 2000 Jul-Aug;212(4):200-5.

PMID:
10994551
4.

High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.

Tang XX, Evans AE, Zhao H, Cnaan A, London W, Cohn SL, Brodeur GM, Ikegaki N.

Clin Cancer Res. 1999 Jun;5(6):1491-6.

5.

TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.

Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.

Cancer. 2004 Oct 15;101(8):1873-81.

6.

Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification.

Eggert A, Ho R, Ikegaki N, Liu XG, Brodeur GM.

Med Pediatr Oncol. 2000 Dec;35(6):623-7.

PMID:
11107132
7.

Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma.

Shimada A, Hirato J, Kuroiwa M, Kikuchi A, Hanada R, Wakai K, Hayashi Y.

Pediatr Blood Cancer. 2008 Feb;50(2):213-7.

PMID:
17941064
8.

Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.

Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R.

Clin Cancer Res. 2001 Nov;7(11):3457-64.

9.

High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.

Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, Himelstein BP.

Clin Cancer Res. 2000 May;6(5):1900-8.

10.

Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.

Zhang Y, Dang C, Ma Q, Shimahara Y.

Oncol Rep. 2005 Jul;14(1):161-71.

PMID:
15944784
11.

Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma.

Kramer K, Cheung NK, Gerald WL, LaQuaglia M, Kushner BH, LeClerc JM, LeSauter L, Saragovi HU.

Eur J Cancer. 1997 Oct;33(12):2098-100.

PMID:
9516861
12.

The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas.

Zhang J, Zheng Y, Wang Y, Tong H.

J Pediatr Hematol Oncol. 2010 Apr;32(3):180-4. doi: 10.1097/MPH.0b013e3181c46bab.

PMID:
20186105
13.

Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody.

LeSauteur L, Maliartchouk S, Le Jeune H, Quirion R, Saragovi HU.

J Neurosci. 1996 Feb 15;16(4):1308-16.

14.

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.

Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC.

J Natl Cancer Inst. 1993 Mar 3;85(5):377-84.

PMID:
8433391
15.

Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma.

Eggert A, Grotzer MA, Ikegaki N, Liu XG, Evans AE, Brodeur GM.

Med Pediatr Oncol. 2000 Dec;35(6):569-72.

PMID:
11107119
16.

Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.

Li P, Gao Y, Ji Z, Zhang X, Xu Q, Li G, Guo Z, Zheng B, Guo X.

J Pediatr Surg. 2004 Oct;39(10):1512-9.

PMID:
15486896
17.

Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma.

Tang XX, Zhao H, Robinson ME, Cnaan A, London W, Cohn SL, Cheung NK, Brodeur GM, Evans AE, Ikegaki N.

Med Pediatr Oncol. 2000 Dec;35(6):656-8.

PMID:
11107140
18.

Neuronal differentiation in human neuroblastoma cells by nerve growth factor following TrkA up-regulation by interferon-gamma.

Shikata A, Shikata T, Sotozono Y, Hosoi H, Matsumura T, Sugimoto T, Sawada T.

Med Pediatr Oncol. 2000 Jun;34(6):394-401.

PMID:
10842245
19.

Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.

Tang XX, Evans AE, Zhao H, Cnaan A, Brodeur GM, Ikegaki N.

Med Pediatr Oncol. 2001 Jan;36(1):80-2.

PMID:
11464911
20.

Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute.

Hishiki T, Saito T, Terui K, Sato Y, Takenouchi A, Yahata E, Ono S, Nakagawara A, Kamijo T, Nakamura Y, Matsunaga T, Yoshida H.

J Pediatr Surg. 2010 Dec;45(12):2293-8. doi: 10.1016/j.jpedsurg.2010.08.021.

PMID:
21129533

Supplemental Content

Support Center